Biostar Microtech International Corp
TWSE:2399

Watchlist Manager
Biostar Microtech International Corp Logo
Biostar Microtech International Corp
TWSE:2399
Watchlist
Price: 20.85 TWD 0.48% Market Closed
Updated: May 19, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

2.8B
-2%
Assets
Growth Rates:
1 Year
-1%
3 Years
-1%
5 Years
-8%
7 Years
-12%
10 Years
-28%
643.7m
+14%
Liabilities
Growth Rates:
1 Year
+14%
3 Years
-2%
5 Years
-38%
7 Years
-27%
10 Years
-49%
2.1B
-5%
Equity
Growth Rates:
1 Year
-5%
3 Years
0%
5 Years
+8%
7 Years
-6%
10 Years
-17%

Balance Sheet Decomposition
Biostar Microtech International Corp

2.8B
Assets
643.7m
Liabilities
2.8B
Assets
643.7m
Liabilities
Current Assets 2.3B
Cash & Short-Term Investments 1.3B
Receivables 182.6m
Other Current Assets 817.9m
Non-Current Assets 501.3m
Long-Term Investments 315m
PP&E 132.1m
Other Non-Current Assets 54.2m
Current Liabilities 606.1m
Accounts Payable 468m
Accrued Liabilities 94.4m
Other Current Liabilities 43.7m
Non-Current Liabilities 37.6m
Long-Term Debt 303k
Other Non-Current Liabilities 37.3m

Balance Sheet
Biostar Microtech International Corp

Rotate your device to view
Balance Sheet
Currency: TWD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
386
1 099
1 362
822
587
755
603
653
748
695
Cash
236
479
475
373
511
452
306
250
353
291
Cash Equivalents
150
620
886
448
77
303
297
403
394
404
Short-Term Investments
572
348
341
393
256
397
899
906
456
592
Total Receivables
912
402
243
643
348
369
204
155
133
183
Accounts Receivables
890
362
231
521
305
339
111
137
115
161
Other Receivables
22
40
11
122
43
29
93
18
18
21
Inventory
913
685
637
930
768
498
621
1 021
902
809
Other Current Assets
39
34
31
66
61
52
28
11
7
9
Total Current Assets
2 821
2 568
2 613
2 853
2 021
2 071
2 355
2 745
2 247
2 288
PP&E Net
175
163
164
233
245
247
138
133
136
132
PP&E Gross
175
0
164
233
245
247
138
133
136
132
Accumulated Depreciation
255
0
228
396
681
614
231
228
212
212
Intangible Assets
0
0
0
171
171
171
0
0
0
0
Long-Term Investments
216
329
342
378
500
549
282
372
370
315
Other Long-Term Assets
139
57
55
71
94
77
33
46
57
54
Total Assets
3 352
N/A
3 117
-7%
3 173
+2%
3 705
+17%
3 031
-18%
3 115
+3%
2 808
-10%
3 296
+17%
2 810
-15%
2 789
-1%
Liabilities
Accounts Payable
623
512
607
711
367
445
437
529
346
468
Accrued Liabilities
106
120
124
198
103
101
106
156
116
94
Short-Term Debt
0
0
0
0
100
95
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
5
1
0
2
2
Other Current Liabilities
89
74
77
95
103
122
81
146
62
42
Total Current Liabilities
818
706
809
1 004
673
768
624
831
525
606
Long-Term Debt
0
0
0
0
0
1
0
0
2
0
Deferred Income Tax
15
9
10
4
6
2
1
1
12
14
Minority Interest
0
0
0
245
294
302
0
0
0
0
Other Liabilities
86
68
64
65
68
42
33
33
23
23
Total Liabilities
919
N/A
783
-15%
883
+13%
1 319
+49%
1 041
-21%
1 115
+7%
659
-41%
864
+31%
562
-35%
644
+14%
Equity
Common Stock
1 781
1 781
1 781
1 781
1 781
1 781
1 781
1 781
1 781
1 781
Retained Earnings
565
460
422
524
125
134
280
597
404
295
Additional Paid In Capital
92
92
92
92
92
92
92
67
67
67
Unrealized Security Profit/Loss
0
23
23
8
9
7
9
7
14
5
Other Equity
5
24
19
2
1
13
13
20
9
9
Total Equity
2 432
N/A
2 334
-4%
2 290
-2%
2 386
+4%
1 990
-17%
2 000
+0%
2 149
+7%
2 431
+13%
2 247
-8%
2 146
-5%
Total Liabilities & Equity
3 352
N/A
3 117
-7%
3 173
+2%
3 705
+17%
3 031
-18%
3 115
+3%
2 808
-10%
3 296
+17%
2 810
-15%
2 789
-1%
Shares Outstanding
Common Shares Outstanding
178
178
178
178
178
178
178
178
178
178

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 138,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.